Published on November 15, 2025
Delhi, India
In a resounding endorsement of its pivotal role in national health innovation, AIIMS New Delhi has clinched the highest national ranking and Gold award for Overall Performance and Institutional Excellence at the 2nd DHR-ICMR Health Research Excellence Summit 2025. Held in New Delhi and organized by the Department of Health Research (DHR) under the Ministry of Health and Family Welfare and the Indian Council of Medical Research (ICMR), the summit celebrated excellence across India’s health research ecosystem. Inaugurated by Union Minister of State for Health and Family Welfare, Smt. Anupriya Singh Patel, the event underscored India’s ascent in global health research, crediting Prime Minister Narendra Modi’s vision for initiatives like MedTech Mitra, Rotavac, and indigenous COVID-19 vaccines. This accolade not only reaffirms AIIMS’s stature but also aligns with the National Education Policy (NEP) 2020’s thrust on interdisciplinary research and self-reliance (Atmanirbhar Bharat). As of November 15, 2025, this recognition arrives amid a surge in medical research funding, positioning AIIMS as a beacon for aspiring institutions.
Key Points:
- Event Scale: Over 100 institutions evaluated; attended by NITI Aayog’s Dr. V.K. Paul as Guest of Honour, alongside scientists and policymakers.
- Award Criteria: Multi-dimensional assessment covering research output, innovation translation, public health impact, capacity building, and funding collaborations.
- Broader Context: Part of ICMR’s 113th Foundation Day celebrations, emphasizing equitable dissemination of research benefits to grassroots communities.
Summit Spotlight: The 2nd DHR-ICMR Health Research Excellence Platform
Launched in 2024, the DHR-ICMR Summit serves as India’s premier forum for benchmarking health research institutions, fostering collaborations, and driving policy-aligned innovations. The 2025 edition, themed around “Health Research for Viksit Bharat,” evaluated participants on metrics like publication impact (e.g., high-citation papers in Scopus-indexed journals) and translational success (e.g., lab-to-market diagnostics). Beyond AIIMS’s sweep, other notables included the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, securing top honors in specialized categories, and ICMR’s own institute earning Silver for Institutional Excellence. The minister’s keynote highlighted a 25% annual rise in health R&D funding since 2020, urging a shift from rote medical education to evidence-based, community-centric models.
Key Points:
- Evaluation Framework: Quantitative (e.g., grant acquisition metrics) + qualitative (e.g., policy influence scores); AIIMS excelled in extramural funding, bagging an additional Gold in that subcategory.
- Key Sessions: Focused on AI integration in diagnostics, vaccine equity, and climate-resilient public health strategies.
- Inaugural Highlights: Patel emphasized “research for all,” linking awards to NEP goals of 6% GDP allocation for education and health by 2030.
AIIMS New Delhi’s Trailblazing Achievements: A Deep Dive
AIIMS New Delhi’s Gold underscores its holistic integration of tertiary care, academia, and research— a model emulated nationwide. The institute’s prowess in churning out over 5,000 high-impact publications annually, many in top-tier journals like The Lancet, has directly informed national guidelines on tuberculosis and maternal health. Its innovation pipeline, including AI-powered telemedicine tools and affordable therapeutics from the National Drug Discovery Institute, exemplifies translational excellence. Capacity building shines through mentorship programs training 1,000+ young researchers yearly, while extramural ties with WHO and NIH have secured $50 million+ in grants over the past five years.
Key Points:
- Research Output: Leads in H-index rankings among Indian medical institutes; pivotal in COVID-19 genomic surveillance.
- Public Health Impact: Evidence-based inputs shaped Ayushman Bharat and National TB Elimination Programme.
- Innovation & Funding: Translated 20+ lab discoveries into clinical tools; 40% grant success rate from competitive pools like ICMR’s Extramural Research scheme.
Leadership Perspectives: Voices from the Vanguard
Professor M. Srinivas, Director of AIIMS New Delhi, hailed the award as a “collective triumph,” crediting the 10,000-strong faculty-staff ecosystem for blending “science, service, and innovation.” Echoing this, Minister Patel’s address positioned such recognitions as catalysts for “Viksit Bharat 2047,” where health research fuels economic growth via biotech exports projected to hit $150 billion by 2030. Dr. V.K. Paul lauded AIIMS’s role in bridging urban-rural health divides through digital health initiatives.
Key Points:
- Srinivas’s Vision: Emphasizes sustained investment in interdisciplinary labs to tackle emerging threats like antimicrobial resistance.
- Policy Alignment: Awards reinforce NITI Aayog’s Health Index, where AIIMS anchors Delhi’s top-tier performance.
- Community Echoes: Social media buzz, including AIIMS’s official X post, amplifies pride in the dual Gold wins.
Challenges and Future Horizons: Scaling Excellence Nationally
While AIIMS’s feat inspires, it spotlights systemic gaps: uneven R&D infrastructure in Tier-2/3 institutes and a researcher-to-population ratio of 1:10,000 (vs. global 1:1,000). The summit called for augmented funding and open-access mandates to democratize knowledge. Looking ahead, AIIMS aims to spearhead AIIMS-like hubs in underserved regions, aligning with the 2025-30 National Health Mission’s $10 billion research infusion.
Key Points:
- Hurdles Addressed: Summit resolutions include streamlined grant processes and gender-inclusive training (women researchers: 35% at AIIMS).
- Expansion Plans: Collaborative networks for 50+ new trials in oncology and rare diseases by 2027.
- Global Ramifications: Bolsters India’s G20 health commitments, enhancing vaccine diplomacy.
